Services
Cell Therapy Solution
Daewoong Pharmaceutical Indonesia (DPI) provides advanced cell therapy solutions manufactured in GMP-certified facilities, in full compliance with global standards, including those established by the International Society for Cell & Gene Therapy (ISCT).
Allogeneic Stem Cell Therapy (UC-MSC, AD-MSC)
Daewoong Pharmaceutical Indonesia  - Allogeneic Stem Cell Therapy (UC-MSC, AD-MSC)
Our allogeneic stem cell therapy utilizes umbilical cord-derived mesenchymal stem cells (UC-MSC), one of the most primitive and potent cell sources. UC-MSCs are collected from healthy donors who undergo rigorous screening and qualification based on international standards.

UC-MSCs offer excellent proliferation and differentiation capabilities, providing therapeutic benefits including anti-aging effects, immune enhancement, inflammation control, and tissue regeneration. As a ready to use product, our allogeneic stem cell therapy ensures convenience and consistency in clinical applications.

In addition, DPI is currently developing allogeneic adipose-derived mesenchymal stem cell (AD-MSC) therapy. AD-MSCs are known for their regenerative and anti-inflammatory potential, and we are expanding our pipeline to offer broader therapeutic options for various disease indications.
Autologous Stem Cell Therapy (AD-MSC)
Autologous stem cell therapy involves the use of a patient’s own adipose-derived mesenchymal stem cells (AD-MSC). This personalized treatment approach ensures long-term safety and minimizes the risk of immune rejection.AD-MSCs provide significant therapeutic effects across multiple indications, including anti-aging, immune modulation, inflammation reduction, and tissue repair. By leveraging the patient’s own cells, autologous therapy offers customized regenerative solutions optimized for individual healthcare needs.
Autologous NK Cell Therapy
Daewoong Pharmaceutical Indonesia - Autologous NK Cell Therapy
Autologous NK (Natural Killer) cell therapy is an immune cell-based treatment that enhances the body’s natural defense mechanisms. NK cells are isolated from the patient’s peripheral blood, then activated and expanded before being reinfused into the patient. This therapy is being developed as a powerful adjuvant option for cancer treatment, immune enhancement, and physical recovery.Autologous NK cells play a critical role in strengthening immune response, targeting abnormal cells, and supporting the recovery of patients with autoimmune or chronic conditions.
Secretome & Exosome Therapy
Daewoong Pharmaceutical Indonesia - Secretome & Exosome Therapy
Beyond cell-based therapy, DPI is advancing cell-free regenerative platforms utilizing secretome and exosome technology the next frontier in regenerative medicine and cosmeceutical innovation.

Secretome is a collection of bioactive molecules secreted by stem cells, including proteins, peptides, growth factors, cytokines, and extracellular vesicles. It functions through paracrine signaling, supporting tissue regeneration, immune modulation, and anti-inflammatory effects.

Exosomes are nanosized extracellular vesicles secreted by MSCs that deliver potent biological signals to target cells. Our UC-MSC-derived exosome product is being developed as the first Made-in-Indonesia exosome therapy, with applications in anti-aging, skin rejuvenation, soothing, elasticity improvement, and wrinkle reduction. UC-MSC-derived exosome product is scheduled for launch in October 2025.